These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22126165)

  • 1. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone.
    LeBaron V; Brody J; Lee EM; Hardin C; Snyder L
    J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations.
    Manfredi PL; Borsook D; Chandler SW; Payne R
    Pain; 1997 Mar; 70(1):99-101. PubMed ID: 9106815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing methadone, a unique analgesic.
    Manfredi PL; Houde RW
    J Support Oncol; 2003; 1(3):216-20. PubMed ID: 15334878
    [No Abstract]   [Full Text] [Related]  

  • 6. Exceptionally high narcotic analgesic requirements in a terminally ill cancer patient.
    Lo SL; Coleman RR
    Clin Pharm; 1986 Oct; 5(10):828-32. PubMed ID: 2430752
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer.
    Latuga NM; Wahler RG
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Getting comfortable with methadone.
    J Support Oncol; 2003; 1(1):52. PubMed ID: 15352643
    [No Abstract]   [Full Text] [Related]  

  • 10. Equianalgesic dosing of opioids.
    Berdine HJ; Nesbit SA
    J Pain Palliat Care Pharmacother; 2006; 20(4):79-84. PubMed ID: 17182514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on Manfredi et al.,Pain, 70 (1997) 199-101.
    River Y; Belgrade M
    Pain; 1998 Jul; 77(1):103-4. PubMed ID: 9755025
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone for pain: No. 75.
    Gazelle G; Fine PG
    J Palliat Med; 2004 Apr; 7(2):303-4. PubMed ID: 15130209
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
    Juba KM; Wahler RG; Daron SM
    J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pain therapy in patients with tumors. According to graduated schedule and hourly plan].
    MMW Fortschr Med; 2003 Oct; 145(40):53. PubMed ID: 14603608
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized clinical trial comparing the safety and efficacy of a hydromorphone titration protocol to usual care in the management of adult emergency department patients with acute severe pain.
    Chang AK; Bijur PE; Gallagher EJ
    Ann Emerg Med; 2011 Oct; 58(4):352-9. PubMed ID: 21507527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine to methadone conversion: an interpretation of published data.
    Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.